By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...
Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and ...
Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...
Regulatory challenges have been even more top of mind than usual given recent upheaval at the FDA. BioSpace spoke to three industry experts about key issues, which include applying new artificial ...
Chennai: Indian Institute of Technology-Madras (IIT-M) released the country's first comprehensive genome database for ...
Discover how Laverdia CA1 (verdinexor) treats canine lymphoma. Learn about the mechanism of action, handling precautions, and ...
After a series of deaths in patients taking Sarepta Therapeutics’ gene therapies, doubt has crept into investor sentiments ...
Researchers at City St. George’s, University of London, have identified a new molecular signature that may explain why ...
Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both ...
One in three people will be diagnosed with cancer in their lifetime, with pancreatic cancer one of the deadliest among them.
Senate Democrats are advancing a new prescription drug pricing agenda they say would lower costs for patients, reduce wasteful health care spending, and strengthen US biomedical innovation, while ...
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results